breast cancer and glp 1 Is GLP-1 Safe for Survivors? Evidence Guidance – Bolt Pharmacy Frontiers | Glucagon-like peptide-1 receptor
Description
[DOI] [PubMed] [Google Scholar] 145.Balestrieri M.L., Rizzo M.R., Barbieri M., Paolisso P., DOnofrio N., Giovane A., Siniscalchi M., Minicucci F., Sardu C., DAndrea D., et al
A 41-year-old woman with brain fog, insomnia, vertigo, neuropathic symptoms, blood pressure lability, postural orthostatic tachycardia syndrome (POTS), dermatographism, macular erythematous rash, flushing, burning skin, severe gastroesophageal reflux, migratory joint pains, vaginal pruritus, intermittent hoarseness, and chemical sensitivity
Youre not alone in this journey, and there are ways to navigate the complexities to achieve sustainable results
In this study, researchers analyzed data from more than 450,000 adults with type 2 diabetes who started either a GLP-1 drug or a dipeptidyl peptidase-4 inhibitor (known as DPP-4 inhibitor)
Rare cases of pulmonary hypertension have been reported with phentermine alone, though the absolute risk appears low
